
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded capsule containing 5-Hydroxytryptophan, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing 5-hydroxytryptophan (oxitriptan) is listed. Products containing it are filed in the directory as homeopathic products, in liquid, spray and solution forms. None of the listed products containing 5-hydroxytryptophan (oxitriptan) is in capsule form.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
5-Hydroxytryptophan (5-HTP) is a serotonin precursor sold in the US as a dietary supplement, which a pharmacy may compound on a prescriber's order.
5-Hydroxytryptophan (5-HTP) is a compound the body makes from the amino acid tryptophan. Enzymes then convert it to serotonin, a brain and gut messenger, and serotonin is further converted to melatonin. Commercial 5-HTP is mostly extracted from Griffonia simplicifolia seeds. A review in the International Journal of Molecular Sciences describes 5-HTP as both a drug and a component of some dietary supplements. An openFDA Drugs@FDA search found no FDA-approved application, so there is no FDA prescription label; the only DailyMed listings containing it are unapproved homeopathic products. Memorial Sloan Kettering lists purported supplement uses such as anxiety, depression, fibromyalgia, insomnia and obesity, rating most of the evidence as limited or preliminary. None is an FDA-approved indication. A prescriber might order 5-HTP compounded in a specific strength, form or combination. Compounded preparations are not FDA-approved and require a prescription.
5-HTP has no FDA drug label and so no boxed warning. Too much serotonin activity can cause serotonin syndrome, a potentially life-threatening reaction that affects mental state, involuntary body functions and muscles. Memorial Sloan Kettering advises that people taking SSRIs, MAO inhibitors, tricyclic antidepressants or other serotonergic drugs avoid 5-HTP unless their prescriber supervises it, and not to combine it with St John's wort or SAM-e. Case reports describe serotonin syndrome with linezolid, mania with an MAO inhibitor, and a scleroderma-like illness with carbidopa. 5-HTP can make urine 5-HIAA test results inaccurate. Contaminated products have been linked to an eosinophilia-myalgia type illness. Reported side effects include nausea, vomiting, diarrhea, headache, trouble sleeping and a fast or irregular heartbeat. No LactMed record or pregnancy data were found in the sources reviewed, so talk to your prescriber or pharmacist before use if you are pregnant or breastfeeding, and about any side effects.
5-HTP is formed from tryptophan by tryptophan hydroxylase (TPH1 and TPH2), the rate-limiting step in serotonin and melatonin biosynthesis; aromatic L-amino acid decarboxylase then converts it to serotonin. Memorial Sloan Kettering states that it crosses the blood-brain barrier and bypasses the tryptophan hydroxylase step. Absorption, bioavailability and half-life data were not found in the sources reviewed. Regulatory status: Drugs@FDA lists no NDA or ANDA, and DailyMed lists only unapproved homeopathic products containing it. The Maffei review (2020) summarizes clinical literature in depression, myoclonus (including combination with carbidopa), obesity and sleep; none of these is an FDA-approved indication. Dosing is per prescriber. Monitor for serotonergic toxicity, particularly with SSRIs, MAO inhibitors, tricyclic antidepressants or linezolid. Purity matters: L-tryptophan supplements were suspended in 1989 after eosinophilia-myalgia syndrome was traced to contaminated synthetic tryptophan from one manufacturer. The Maffei review reports no definitive 5-HTP toxicity cases apart from one unresolved case and calls concerns about a trace impurity ("peak X") not credible, but sourcing and certificate-of-analysis review remain relevant. 5-HTP may interfere with urine 5-HIAA testing.
Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.
Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth